Higher expenditure boosts Mako's revenue
This article was originally published in Clinica
Executive Summary
In its first earnings release since becoming a publicly-listed company, minimally-invasive knee implant specialist Mako Surgical recorded a significant leap in revenue for the fourth quarter of 2007. The Fort Lauderdale, Florida-based company, which completed an IPO in February (see Clinica No 1295, p 17), reported an increase in revenue from $28,000 in Q4 2006 to approximately $416,000 for the same period in 2007. Full-year revenue for fiscal 2007 reached $771,000, up from $62,000 in 2006.